(Q38479571)

3 September 2017

title

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia (English)

1 reference

3 September 2017

1 reference

Langnas AN

1

1 reference

3 September 2017

Markin RS

series ordinal

2

1 reference

3 September 2017

Cattral MS

series ordinal

3

1 reference

3 September 2017

Naides SJ

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

3 September 2017

1 reference

3 September 2017

volume

22

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

1661-1665

1 reference

Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

Hepatitis C Virus Not Found in Fulminant Non-A, Non-B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

Experimental parvoviral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Aplastic anemia after liver transplantation for fulminant liver failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Human parvovirus B19 infection among hospital staff members after contact with infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Detection of human parvovirus using a molecularly cloned probe

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Thrombocytopenia induced by human parvovirus B19 infections.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Chronic bone marrow failure due to persistent B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840220608

7 January 2021

Identifiers

DOI

10.1002/HEP.1840220608

1 reference

3 September 2017

1 reference